Inhibition of acquired immunodeficiency syndrome virus by oligodeoxynucleoside methylphosphonates
about
Effect of a single 3'-methylene phosphonate linkage on the conformation of an A-DNA octamer double helixInduction of chronic human immunodeficiency virus infection is blocked in vitro by a methylphosphonate oligodeoxynucleoside targeted to a U3 enhancer elementRegulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cellsInhibition of human immunodeficiency virus in early infected and chronically infected cells by antisense oligodeoxynucleotides and their phosphorothioate analoguesCholesteryl-conjugated oligonucleotides: synthesis, properties, and activity as inhibitors of replication of human immunodeficiency virus in cell cultureLong-term treatment of human immunodeficiency virus-infected cells with antisense oligonucleotide phosphorothioatesSolid-Phase Supports for Oligonucleotide SynthesisIntracellular availability of unmodified, phosphorothioated and liposomally encapsulated oligodeoxynucleotides for antisense activity.Inhibition of influenza virus replication by phosphorothioate oligodeoxynucleotides.Newly designed six-membered azasugar nucleotide-containing phosphorothioate oligonucleotides as potent human immunodeficiency virus type 1 inhibitors.A monoclonal antibody extends the half-life of an anti-HIV oligodeoxynucleotide and targets it to CD4+ cells.Antiviral therapy for human immunodeficiency virus infectionsDNA and RNA derivatives to optimize distribution and deliveryInhibition of Rev activity and human immunodeficiency virus type 1 replication by antisense oligodeoxynucleotide phosphorothioate analogs directed against the Rev-responsive element.Antisense agents in cancer research and therapeutics.Specific inhibition of human immunodeficiency virus type 1 replication by antisense oligonucleotides: an in vitro model for treatment.Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice.Site-specific excision from RNA by RNase H and mixed-phosphate-backbone oligodeoxynucleotides.Innovations in the use of antisense oligonucleotides.Concepts and trends in antiviral chemotherapy in the period of AIDS: a review.Design and development of antisense drugs.5'-,3'-inverted thymidine-modified antisense oligodeoxynucleotide targeting midkine. Its design and application for cancer therapy.Evaluation of some properties of a phosphorodithioate oligodeoxyribonucleotide for antisense application.Targeting RNase L to human immunodeficiency virus RNA with 2-5A-antisense.Inhibition of HIV-LTR gene expression by oligonucleotides targeted to the TAR elementMixed backbone antisense oligonucleotides: design, biochemical and biological properties of oligonucleotides containing 2'-5'-ribo- and 3'-5'-deoxyribonucleotide segments.Deprotection of methylphosphonate oligonucleotides using a novel one-pot procedure.Synthesis and base-pairing properties of the nuclease-resistant alpha-anomeric dodecaribonucleotide alpha-[r(UCUUAACCCACA)]Regiospecific inhibition of DNA duplication by antisense phosphate-methylated oligodeoxynucleotidesTreatment of AIDS with drugs targeted to inhibit different stages of the HIV life cycle.'Hairpin' catalytic RNA model: evidence for helices and sequence requirement for substrate RNA.Sequence dependent effects in methylphosphonate deoxyribonucleotide double and triple helical complexes.The application of the AMB protective group in the solid-phase synthesis of methylphosphonate DNA analogues.Number and distribution of methylphosphonate linkages in oligodeoxynucleotides affect exo- and endonuclease sensitivity and ability to form RNase H substratesRNase H cleavage of RNA hybridized to oligonucleotides containing methylphosphonate, phosphorothioate and phosphodiester bonds.Lethal oxidative damage to human immunodeficiency virus by human recombinant myeloperoxidase.
P2860
Q27659299-0A7FEBE4-EAC1-48AE-BECC-A90B8D899FBAQ28323598-92694228-62E3-4504-9554-50B881CA337DQ28339853-6F10F9D3-0D52-4E42-81A4-15A0DC82E9FDQ28355337-73A9559D-9ED3-4245-9DDD-40672E357F65Q28359555-701BCB14-6B9B-470F-89AA-D287B597AA8FQ28378692-7B61FA32-E622-46B2-A163-F2C5BCD19608Q29999315-90567A41-0A3C-41CB-B76C-91BDE1ABF07FQ31009736-CD78F3DC-8136-4152-A723-6141DA409591Q33563974-B42D5BF4-0F30-4DDD-8740-2FE1C414AD7CQ34076980-C5C2C6D3-3D70-4EA3-816A-D9666C087366Q34780339-92853EB3-E5E8-4D98-8C70-D86C0A4735F9Q35366050-B3AF8885-7D3A-42C0-BD24-F60EF53DFAEAQ35858691-97EC2826-9F78-4C67-9F35-7E3FBA4A48DBQ36654713-811A73F9-9D32-49DC-8702-CAACF9294A11Q37220809-EC12055C-ED42-4B54-81F6-E185E9B6CF33Q37313430-96E26C76-B990-463D-9D46-795A8E1E9E22Q37585661-7D8F6DD8-6548-46BA-9D4F-000BFD1FA7D2Q37696968-63812BD3-C317-437A-9420-273EAD56E5E1Q37783034-AD5B5BD2-B25C-4C81-B0C8-5388CC0F539AQ37937195-D15520D5-170A-470F-8742-F5CBF924ED2DQ38089175-6A41ED91-4687-49FB-BB5D-5D0F448EDC7DQ38290099-64E0D660-0E8E-44D5-A3C5-61F43F8FCD8AQ38313512-5044516A-6966-478F-81D7-6A67BF47951DQ38329856-559B49BC-C027-4D34-AB82-CA93904B1095Q38334658-125A7A90-F7CA-4875-92A6-0C6CE4DC1C73Q38349283-BFCB3304-ED53-4ED8-B8D3-F3CB98E33E78Q40406767-37DD91A1-B0D5-4CD5-B236-5436B2F2842CQ40421057-9050DFED-B130-41D1-B0D4-EE17454DB2B1Q40450702-3478631A-021F-46A9-83B7-02B1BF4A7B91Q40468453-BD13ED41-9A16-49F3-82C7-3953437EB332Q40513852-4C648BF6-87EA-47FD-8646-631173E7EC21Q40517590-6142E8B7-3D8B-48EA-B2EF-FC4256E38C3EQ40519835-0D8E328B-FF94-4B76-B928-D49B6F447C11Q40537453-19690275-AB7E-4A4C-8FF4-4E9B8C7AFDAEQ40539121-05D40B22-42B3-4E40-97D0-6CA194DC0FAEQ41623881-FD37B922-7483-4421-8D4D-68A1BDCDC507
P2860
Inhibition of acquired immunodeficiency syndrome virus by oligodeoxynucleoside methylphosphonates
description
1988 nî lūn-bûn
@nan
1988 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Inhibition of acquired immunod ...... ynucleoside methylphosphonates
@ast
Inhibition of acquired immunod ...... ynucleoside methylphosphonates
@en
Inhibition of acquired immunod ...... ynucleoside methylphosphonates
@nl
type
label
Inhibition of acquired immunod ...... ynucleoside methylphosphonates
@ast
Inhibition of acquired immunod ...... ynucleoside methylphosphonates
@en
Inhibition of acquired immunod ...... ynucleoside methylphosphonates
@nl
prefLabel
Inhibition of acquired immunod ...... ynucleoside methylphosphonates
@ast
Inhibition of acquired immunod ...... ynucleoside methylphosphonates
@en
Inhibition of acquired immunod ...... ynucleoside methylphosphonates
@nl
P2093
P2860
P356
P1476
Inhibition of acquired immunod ...... ynucleoside methylphosphonates
@en
P2093
J Goodchild
M P Civeira
P C Zamecnik
P2860
P304
P356
10.1073/PNAS.85.20.7448
P407
P577
1988-10-01T00:00:00Z